Article(id=1325225076769042663, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325224995202409429, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.03.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1746547200000, receivedDateStr=2025-05-07, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887879793, onlineDateStr=2026-11-05, pubDate=1773072000000, pubDateStr=2026-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887879793, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887879793, creator=13701087609, updateTime=1793887879793, updator=13701087609, issue=Issue{id=1325224995202409429, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='3', pageStart='257', pageEnd='375', issueExtLink='null', onlineDate='null', pubDate='1773072000000', pubDateStr='2026-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887860345, creator='13701087609', updateTime=1793946124191, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325469371547648240, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325224995202409429, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325469371547648241, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325224995202409429, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=257, endPage=267, ext={EN=ArticleExt(id=1325225076966174952, articleId=1325225076769042663, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in Clinical Transformation of RNA Drugs with Non-viral Delivery Systems, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=

RNA-based therapeutics represent a pivotal modality in precision medicine, and their clinical advancement hinges on the development of highly efficient and safe delivery systems. Given their superior safety, substantial drug-loading capacity, and scalability for industrial production, non-viral delivery systems have become predominant in the field. This review systematically summarizes the approved RNA drugs and analyzes their core delivery strategies in detail. Furthermore, it discusses the key bottlenecks limiting the clinical translation of non-viral platforms, including low delivery efficiency, inefficient endosomal escape, short systemic circulation time, and insufficient extrahepatic targeting capabilities, as well as existing mitigating strategies, with the aim of promoting more effective clinical transformation of RNA therapeutics.

, authors=Shuqi YIN1, Ting PAN1, 2, Jun HE1, *, authorsList=Shuqi YIN, Ting PAN, Jun HE, authorCompany=null, correspAuthors=Jun HE, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325225077255581929, articleId=1325225076769042663, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=RNA药物临床转化中非病毒载体递送策略的研究进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

RNA药物作为精准治疗的关键组成部分,其临床转化高度依赖于高效、安全的递送系统。非病毒载体递送系统因安全性高、载药量大、易工业化生产等优势,已成为该领域的研发主流。该文系统综述了已上市的各类RNA药物,并重点剖析了其核心的递送策略。此外,文章进一步探讨了非病毒递送系统在临床转化中面临的核心瓶颈,包括递送效率低、内体逃逸困难、体内循环时间短、肝外靶向能力不足等挑战,以及已有的解决方案,以期推动有效的RNA药物临床转化。

, authors=尹舒琪1, 潘婷1, 2, 何军1, *, authorsList=尹舒琪, 潘婷, 何军, authorCompany=null, correspAuthors=何军, authorNote=

尹舒琪,硕士,从事新型药物递送系统的研究。

, correspAuthorsNote=
何军,研究员,从事新型注射给药系统产业化关键技术的研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=kak8ivq1Ka6ytr+JpS2iEA==, magXml=3+tCwlY4rsL28MmwiYBJQw==, pdfUrl=null, pdf=1dJXOQb72dwk9loXZnc8ew==, pdfFileSize=2194918, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=bHcTtcG6neLWa15oj4pDvw==, mapNumber=null, fund=null)}, authors=[Author(id=1325225077658235121, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225078916526323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225077658235121, language=EN, stringName=Shuqi YIN, firstName=Shuqi, middleName=null, lastName=YIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225078992023796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225077658235121, language=CN, stringName=尹舒琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203, bio={"content":"

尹舒琪,硕士,从事新型药物递送系统的研究。

"}, bioImg=null, bioContent=

尹舒琪,硕士,从事新型药物递送系统的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1325225079109464310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225079201739001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079109464310, language=EN, stringName=Ting PAN, firstName=Ting, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
2. School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225079277236474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079109464310, language=CN, stringName=潘婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203
2.复旦大学药学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)]), AuthorCompany(id=1325225077561766125, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=2., ext=[AuthorCompanyExt(id=1325225077574349038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077561766125, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1325225077586931951, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077561766125, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院,上海 201203)])]), Author(id=1325225079344345340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225079432425726, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079344345340, language=EN, stringName=Jun HE, firstName=Jun, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225079499534591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079344345340, language=CN, stringName=何军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)])])], keywords=[Keyword(id=1325225079604392192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=EN, orderNo=1, keyword=nucleic acid drug), Keyword(id=1325225079675695361, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=EN, orderNo=2, keyword=non-viral delivery system), Keyword(id=1325225079751192834, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=EN, orderNo=3, keyword=lipid nanoparticle), Keyword(id=1325225079843467523, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=EN, orderNo=4, keyword=endosomal escape), Keyword(id=1325225079910576388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=EN, orderNo=5, keyword=clinical transformation), Keyword(id=1325225079977685253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=EN, orderNo=6, keyword=research progress), Keyword(id=1325225080061571334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=CN, orderNo=1, keyword=核酸药物), Keyword(id=1325225080128680199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=CN, orderNo=2, keyword=非病毒递送系统), Keyword(id=1325225080199983368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=CN, orderNo=3, keyword=脂质纳米粒), Keyword(id=1325225080267092233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=CN, orderNo=4, keyword=内体逃逸), Keyword(id=1325225080317423882, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=CN, orderNo=5, keyword=临床转化), Keyword(id=1325225080380338443, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, language=CN, orderNo=6, keyword=研究进展)], refs=[Reference(id=1325225080615219470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG X G, KONG N, ZHANG X C, et al.The landscape of mRNA nanomedicine [J].Nat Med, 2022, 28(11): 2273-2287., articleTitle=null, refAbstract=null), Reference(id=1325225080678134031, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=GILBERT W V, NACHTERGAELE S.mRNA Regulation by RNA Modifications [J].Annu Rev Biochem, 2023, 92: 175-198., articleTitle=null, refAbstract=null), Reference(id=1325225080741048592, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=CROOKE S T, BAKER B F, CROOKE R M, et al.Antisense technology: an overview and prospectus [J].Nat Rev Drug Discov, 2021, 20(6): 427-453., articleTitle=null, refAbstract=null), Reference(id=1325225080816546065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Labels for NDA 209531 [EB/OL].(2016-12-23)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209531., articleTitle=null, refAbstract=null), Reference(id=1325225080892043538, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=VAILLANT A.Efficacy and safety of bepirovirsen in hepatitis B [J].N Engl J Med, 2023, 388(12): 1146-1148., articleTitle=null, refAbstract=null), Reference(id=1325225080954958099, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=TANG Q, KHVOROVA A.RNAi-based drug design:considerations and future directions [J].Nat Rev Drug Discov, 2024, 23(5): 341-364., articleTitle=null, refAbstract=null), Reference(id=1325225081026261268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Labels for NDA 214012 [EB/OL].(2021-12-22)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214012., articleTitle=null, refAbstract=null), Reference(id=1325225081101758741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ROHNER E, YANG R, FOO K S, et al.Unlocking the promise of mRNA therapeutics [J].Nat Biotechnol, 2022,40(11): 1586-1600., articleTitle=null, refAbstract=null), Reference(id=1325225081173061910, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Approval history, letters, reviews, and related documents – mRESVIA [EB/OL].(2024-10-04)[2024-12-14].https://www.fda.gov/vaccines-blood-biologics/vaccines/mresvia., articleTitle=null, refAbstract=null), Reference(id=1325225081240170775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=DANELLI L.Personalized neoantigen therapy for melanoma immunotherapy [J].Nat Cancer, 2024, 5(12): 1783., articleTitle=null, refAbstract=null), Reference(id=1325225081307279640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CUI H, ZHU X Y, LI S Y, et al.Liver-targeted delivery of oligonucleotides with N-acetylgalactosamine conjugation [J].ACS Omega, 2021, 6(25): 16259-16265., articleTitle=null, refAbstract=null), Reference(id=1325225081374388505, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Labels for NDA 217388 [EB/OL].(2023-12-21)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217388., articleTitle=null, refAbstract=null), Reference(id=1325225081445691674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=BALLANTYNE C M, VASAS S, AZIZAD M, et al.Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia [J].N Engl J Med, 2024, 391(10):899-912., articleTitle=null, refAbstract=null), Reference(id=1325225081516994843, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Labels for NDA 215842 [EB/OL].(2023-09-29)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215842., articleTitle=null, refAbstract=null), Reference(id=1325225081579909404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI Y Y, SHI M X, WANG Y, et al.Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications[J].Signal Transduct Target Ther, 2024, 9(1): 322., articleTitle=null, refAbstract=null), Reference(id=1325225081638629661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=AKINC A, QUERBES W, DE S, et al.Targeted delivery of rnai therapeutics with endogenous and exogenous ligand-based mechanisms [J].Mol Ther, 2010, 18(7): 1357-1364., articleTitle=null, refAbstract=null), Reference(id=1325225081701544222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ALBERTSEN C H, KULKARNI J A, WITZIGMANN D,et al.The role of lipid components in lipid nanoparticles for vaccines and gene therapy [J].Adv Drug Deliv Rev, 2022,188: 114416., articleTitle=null, refAbstract=null), Reference(id=1325225081764458783, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Labels for NDA 210922 [EB/OL].(2018-08-10)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922., articleTitle=null, refAbstract=null), Reference(id=1325225081831567648, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Approval history, letters, reviews, and related documents – Comirnaty [EB/OL].(2024-10-11)[2024-12-14].https://www.fda.gov/vaccines-blood-biologics/comirnaty., articleTitle=null, refAbstract=null), Reference(id=1325225081923842337, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Approval history, letters, reviews, and related documents – Spikevax [EB/OL].(2024-09-06)[2024-12-14].https://www.fda.gov/vaccines-blood-biologics/spikevax., articleTitle=null, refAbstract=null), Reference(id=1325225081978368290, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=JU Y, LEE W S, PILKINGTON E H, et al.Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine [J].ACS Nano, 2022, 16(8):11769-11780., articleTitle=null, refAbstract=null), Reference(id=1325225082066448675, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=CULLIS P R, FELGNER P L.The 60-year evolution of lipid nanoparticles for nucleic acid delivery [J].Nat Rev Drug Discov, 2024, 23(9): 709-722., articleTitle=null, refAbstract=null), Reference(id=1325225082137751844, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=江翠平, 王 媛, 肖海燕, 等.非病毒型载体聚乙烯亚胺在基因递送应用中的研究进展[J].药学学报, 2020, 55(12):2869-2882., articleTitle=null, refAbstract=null), Reference(id=1325225082209055013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG H Z, YUAN Y, QIN L, et al.Tunable rigidity of PLGA shell-lipid core nanoparticles for enhanced pulmonary siRNA delivery in 2D and 3D lung cancer cell models [J].J Control Release, 2024, 366: 746-760., articleTitle=null, refAbstract=null), Reference(id=1325225082271969574, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=KRISHNAN N, JIANG Y, ZHOU J R, et al.A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering [J].Nat Nanotechnol,2023, 19(3): 345-353., articleTitle=null, refAbstract=null), Reference(id=1325225082343272743, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHUO Y, LUO Z, ZHU Z, et al.Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes [J].Nat Nanotechnol, 2024, 19(12): 1858-1868., articleTitle=null, refAbstract=null), Reference(id=1325225082410381608, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=VALE N, DUARTE D, SILVA S, et al.Cell-penetrating peptides in oncologic pharmacotherapy: a review [J].Pharmacol Res, 2020, 162: 105231., articleTitle=null, refAbstract=null), Reference(id=1325225082498461993, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=LAM K, LEUNG A, MARTIN A, et al.Unsaturated, trialkyl ionizable lipids are versatile lipid‐nanoparticle components for therapeutic and vaccine applications [J].Adv Mater, 2023,35(15): e2209624., articleTitle=null, refAbstract=null), Reference(id=1325225082569765162, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=GILLERON J, QUERBES W, ZEIGERER A, et al.Image-based analysis of lipid nanoparticle-mediated siRNA delivery,intracellular trafficking and endosomal escape [J].Nat Biotechnol, 2013, 31(7): 638-646., articleTitle=null, refAbstract=null), Reference(id=1325225082649456939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=XUE L L, ZHAO G, GONG N Q, et al.Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery [J].Nat Nanotechnol, 2025, 20(1): 132-143., articleTitle=null, refAbstract=null), Reference(id=1325225082750120236, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEUNG T H, FUCHS A, SHOICHET M S.Acid‐responsive polymer additives increase RNA transfection from lipid nanoparticles [J].Adv Funct Mater, 2025, 35(2):2413220., articleTitle=null, refAbstract=null), Reference(id=1325225082875949357, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG H Y, WANG Y S, YUAN C Z, et al.Polyethylene glycol(PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats [J].NPJ Vaccines, 2023, 8(1): 169., articleTitle=null, refAbstract=null), Reference(id=1325225083001778478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM J, JOZIC A, LIN Y X, et al.Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation [J].ACS Nano, 2022, 16(9): 14792-14806., articleTitle=null, refAbstract=null), Reference(id=1325225083073081647, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J, LI R R, FU Q H, et al.Designed microchannel-based lipid nanoparticles encapsulated siRNA targeting gasdermin D for sepsis management via pulmonary delivery [J].Nano Today, 2025, 61: 102653., articleTitle=null, refAbstract=null), Reference(id=1325225083144384816, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG X G, LIU C, SHARMA S N, et al.Oral delivery of liquid mRNA therapeutics by engineered capsule for treatment of preclinical intestinal disease [J].Sci Transl Med, 2025,17(807): eadu1493., articleTitle=null, refAbstract=null), Reference(id=1325225083211493681, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=MELERO I, CASTANON E, ALVAREZ M, et al.Intratumoural administration and tumour tissue targeting of cancer immunotherapies [J].Nat Rev Clin Oncol, 2021,18(9): 558-576., articleTitle=null, refAbstract=null), Reference(id=1325225083282796850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=SUN X Q, ZHANG Y, LI J Q, et al.Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy [J].Nat Nanotechnol, 2021, 16(11): 1260-1270., articleTitle=null, refAbstract=null), Reference(id=1325225083358294323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=KRANZ L M, DIKEN M, HAAS H, et al.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy [J].Nature, 2016, 534(7607): 396-401., articleTitle=null, refAbstract=null), Reference(id=1325225083429597492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG Q, WEI T, FARBIAK L, et al.Selective organ targeting(SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing [J].Nat Nanotechnol,2020, 15(4): 313-320., articleTitle=null, refAbstract=null), Reference(id=1325225083521872181, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=FEI Y, YU X L, LIU P Y, et al.Simplified lipid nanoparticles for tissue‐ and cell‐targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model [J].Adv Mater, 2024, 36(48): e2409812., articleTitle=null, refAbstract=null), Reference(id=1325225083584786742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU S, CHENG Q, WEI T, et al.Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing [J].Nat Mater, 2021, 20(5):701-710., articleTitle=null, refAbstract=null), Reference(id=1325225083647701303, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J X, GRIMM D.A breath of fresh air: targeted non-viral in vivo gene correction in the mammalian lung [J].Signal Transduct Target Ther, 2024, 9(1): 286., articleTitle=null, refAbstract=null), Reference(id=1325225083714810168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=PAUNOVSKA K, LOUGHREY D, DAHLMAN J E.Drug delivery systems for RNA therapeutics [J].Nat Rev Genet,2022, 23(5): 265-280., articleTitle=null, refAbstract=null), Reference(id=1325225083807084857, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=SIVARAM A J, WARDIANA A, HOWARD C B, et al.Recent advances in the generation of antibody-nanomaterial conjugates [J].Adv Healthc Mater, 2018, 7(1): 1700607., articleTitle=null, refAbstract=null), Reference(id=1325225083882582330, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE N K, WANG C P J, LIM J, et al.Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities [J].Nano Converg, 2021, 8(1): 24., articleTitle=null, refAbstract=null), Reference(id=1325225083979051323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=BRÜCKNER M, SIMON J, LANDFESTER K, et al.The conjugation strategy affects antibody orientation and targeting properties of nanocarriers [J].Nanoscale, 2021, 13(21):9816-9824., articleTitle=null, refAbstract=null), Reference(id=1325225084046160188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=MALECOVA B, BURKE R S, COCHRAN M, et al.Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates(AOCs) [J].Nucleic Acids Res,2023, 51(12): 5901-5910., articleTitle=null, refAbstract=null), Reference(id=1325225084121657661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y, GU X Y, HUANG L L, et al.Enhancing precision medicine: bispecific antibody-mediated targeted delivery of lipid nanoparticles for potential cancer therapy [J].Int J Pharm, 2024, 654: 123990., articleTitle=null, refAbstract=null), Reference(id=1325225084205543742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=LOGAN A, HOWARD C B, HUDA P, et al.Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma [J].J Control Release, 2024, 367: 806-820., articleTitle=null, refAbstract=null), Reference(id=1325225084285235519, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=陶钰萍, 赵珍玉, 李又欣, 等.siRNA新型非病毒载体递送策略新进展[J].中国医药工业杂志, 2023, 54(4): 471-480., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325225080464224524, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, awardId=23S41900200, language=CN, fundingSource=上海市“科技创新行动计划”生物医药科技支撑专项项目(23S41900200), fundOrder=null, country=null), Fund(id=1325225080531333389, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, awardId=23J21900600, language=CN, fundingSource=上海市“科技创新行动计划”细胞与基因治疗专项项目(23J21900600), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)]), AuthorCompany(id=1325225077561766125, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=2., ext=[AuthorCompanyExt(id=1325225077574349038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077561766125, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1325225077586931951, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077561766125, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.03.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.03.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.03.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.03.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1773072000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
RNA药物临床转化中非病毒载体递送策略的研究进展
尹舒琪 1 , 潘婷 1, 2 , 何军 1, *
中国医药工业杂志 | 专论与综述 2026,57(3): 257-267
收起
收藏切换
中国医药工业杂志 |专论与综述 2026 , 57 (3) : 257 -267
RNA药物临床转化中非病毒载体递送策略的研究进展
全屏
[Author(id=1325225077658235121, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225078916526323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225077658235121, language=EN, stringName=Shuqi YIN, firstName=Shuqi, middleName=null, lastName=YIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225078992023796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225077658235121, language=CN, stringName=尹舒琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203, bio={"content":"

尹舒琪,硕士,从事新型药物递送系统的研究。

"}, bioImg=null, bioContent=

尹舒琪,硕士,从事新型药物递送系统的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1325225079109464310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225079201739001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079109464310, language=EN, stringName=Ting PAN, firstName=Ting, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
2. School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225079277236474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079109464310, language=CN, stringName=潘婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203
2.复旦大学药学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)]), AuthorCompany(id=1325225077561766125, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=2., ext=[AuthorCompanyExt(id=1325225077574349038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077561766125, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1325225077586931951, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077561766125, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院,上海 201203)])]), Author(id=1325225079344345340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225079432425726, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079344345340, language=EN, stringName=Jun HE, firstName=Jun, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225079499534591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, authorId=1325225079344345340, language=CN, stringName=何军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225077482074346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, xref=1., ext=[AuthorCompanyExt(id=1325225077490462955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225077503045868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225076769042663, companyId=1325225077482074346, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203)])])]
尹舒琪1, 潘婷1, 2, 何军1, *
作者信息
  • 1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203
  • 2.复旦大学药学院,上海 201203
通讯作者:
何军,研究员,从事新型注射给药系统产业化关键技术的研究。
作者简介:

尹舒琪,硕士,从事新型药物递送系统的研究。

Advances in Clinical Transformation of RNA Drugs with Non-viral Delivery Systems
Shuqi YIN1, Ting PAN1, 2, Jun HE1, *
Affiliations
  • 1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2. School of Pharmacy, Fudan University, Shanghai 201203
出版时间: 2026-03-10 doi: 10.16522/j.cnki.cjph.2026.03.001
文章导航
收藏切换

RNA药物作为精准治疗的关键组成部分,其临床转化高度依赖于高效、安全的递送系统。非病毒载体递送系统因安全性高、载药量大、易工业化生产等优势,已成为该领域的研发主流。该文系统综述了已上市的各类RNA药物,并重点剖析了其核心的递送策略。此外,文章进一步探讨了非病毒递送系统在临床转化中面临的核心瓶颈,包括递送效率低、内体逃逸困难、体内循环时间短、肝外靶向能力不足等挑战,以及已有的解决方案,以期推动有效的RNA药物临床转化。

核酸药物  /  非病毒递送系统  /  脂质纳米粒  /  内体逃逸  /  临床转化  /  研究进展

RNA-based therapeutics represent a pivotal modality in precision medicine, and their clinical advancement hinges on the development of highly efficient and safe delivery systems. Given their superior safety, substantial drug-loading capacity, and scalability for industrial production, non-viral delivery systems have become predominant in the field. This review systematically summarizes the approved RNA drugs and analyzes their core delivery strategies in detail. Furthermore, it discusses the key bottlenecks limiting the clinical translation of non-viral platforms, including low delivery efficiency, inefficient endosomal escape, short systemic circulation time, and insufficient extrahepatic targeting capabilities, as well as existing mitigating strategies, with the aim of promoting more effective clinical transformation of RNA therapeutics.

nucleic acid drug  /  non-viral delivery system  /  lipid nanoparticle  /  endosomal escape  /  clinical transformation  /  research progress
尹舒琪, 潘婷, 何军. RNA药物临床转化中非病毒载体递送策略的研究进展. 中国医药工业杂志, 2026 , 57 (3) : 257 -267 . DOI: 10.16522/j.cnki.cjph.2026.03.001
Shuqi YIN, Ting PAN, Jun HE. Advances in Clinical Transformation of RNA Drugs with Non-viral Delivery Systems[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (3) : 257 -267 . DOI: 10.16522/j.cnki.cjph.2026.03.001
  • 上海市“科技创新行动计划”生物医药科技支撑专项项目(23S41900200)
  • 上海市“科技创新行动计划”细胞与基因治疗专项项目(23J21900600)
参考文献 引证文献
排序方式:
[1]
HUANG X G, KONG N, ZHANG X C, et al.The landscape of mRNA nanomedicine [J].Nat Med, 2022, 28(11): 2273-2287.
[2]
GILBERT W V, NACHTERGAELE S.mRNA Regulation by RNA Modifications [J].Annu Rev Biochem, 2023, 92: 175-198.
[3]
CROOKE S T, BAKER B F, CROOKE R M, et al.Antisense technology: an overview and prospectus [J].Nat Rev Drug Discov, 2021, 20(6): 427-453.
[4]
FDA.Labels for NDA 209531 [EB/OL].(2016-12-23)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209531.
[5]
VAILLANT A.Efficacy and safety of bepirovirsen in hepatitis B [J].N Engl J Med, 2023, 388(12): 1146-1148.
[6]
TANG Q, KHVOROVA A.RNAi-based drug design:considerations and future directions [J].Nat Rev Drug Discov, 2024, 23(5): 341-364.
[7]
FDA.Labels for NDA 214012 [EB/OL].(2021-12-22)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214012.
[8]
ROHNER E, YANG R, FOO K S, et al.Unlocking the promise of mRNA therapeutics [J].Nat Biotechnol, 2022,40(11): 1586-1600.
[9]
FDA.Approval history, letters, reviews, and related documents – mRESVIA [EB/OL].(2024-10-04)[2024-12-14].https://www.fda.gov/vaccines-blood-biologics/vaccines/mresvia.
[10]
DANELLI L.Personalized neoantigen therapy for melanoma immunotherapy [J].Nat Cancer, 2024, 5(12): 1783.
[11]
CUI H, ZHU X Y, LI S Y, et al.Liver-targeted delivery of oligonucleotides with N-acetylgalactosamine conjugation [J].ACS Omega, 2021, 6(25): 16259-16265.
[12]
FDA.Labels for NDA 217388 [EB/OL].(2023-12-21)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217388.
[13]
BALLANTYNE C M, VASAS S, AZIZAD M, et al.Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia [J].N Engl J Med, 2024, 391(10):899-912.
[14]
FDA.Labels for NDA 215842 [EB/OL].(2023-09-29)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215842.
[15]
SHI Y Y, SHI M X, WANG Y, et al.Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications[J].Signal Transduct Target Ther, 2024, 9(1): 322.
[16]
AKINC A, QUERBES W, DE S, et al.Targeted delivery of rnai therapeutics with endogenous and exogenous ligand-based mechanisms [J].Mol Ther, 2010, 18(7): 1357-1364.
[17]
ALBERTSEN C H, KULKARNI J A, WITZIGMANN D,et al.The role of lipid components in lipid nanoparticles for vaccines and gene therapy [J].Adv Drug Deliv Rev, 2022,188: 114416.
[18]
FDA.Labels for NDA 210922 [EB/OL].(2018-08-10)[2024-12-14].https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922.
[19]
FDA.Approval history, letters, reviews, and related documents – Comirnaty [EB/OL].(2024-10-11)[2024-12-14].https://www.fda.gov/vaccines-blood-biologics/comirnaty.
[20]
FDA.Approval history, letters, reviews, and related documents – Spikevax [EB/OL].(2024-09-06)[2024-12-14].https://www.fda.gov/vaccines-blood-biologics/spikevax.
[21]
JU Y, LEE W S, PILKINGTON E H, et al.Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine [J].ACS Nano, 2022, 16(8):11769-11780.
[22]
CULLIS P R, FELGNER P L.The 60-year evolution of lipid nanoparticles for nucleic acid delivery [J].Nat Rev Drug Discov, 2024, 23(9): 709-722.
[23]
江翠平, 王 媛, 肖海燕, 等.非病毒型载体聚乙烯亚胺在基因递送应用中的研究进展[J].药学学报, 2020, 55(12):2869-2882.
[24]
WANG H Z, YUAN Y, QIN L, et al.Tunable rigidity of PLGA shell-lipid core nanoparticles for enhanced pulmonary siRNA delivery in 2D and 3D lung cancer cell models [J].J Control Release, 2024, 366: 746-760.
[25]
KRISHNAN N, JIANG Y, ZHOU J R, et al.A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering [J].Nat Nanotechnol,2023, 19(3): 345-353.
[26]
ZHUO Y, LUO Z, ZHU Z, et al.Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes [J].Nat Nanotechnol, 2024, 19(12): 1858-1868.
[27]
VALE N, DUARTE D, SILVA S, et al.Cell-penetrating peptides in oncologic pharmacotherapy: a review [J].Pharmacol Res, 2020, 162: 105231.
[28]
LAM K, LEUNG A, MARTIN A, et al.Unsaturated, trialkyl ionizable lipids are versatile lipid‐nanoparticle components for therapeutic and vaccine applications [J].Adv Mater, 2023,35(15): e2209624.
[29]
GILLERON J, QUERBES W, ZEIGERER A, et al.Image-based analysis of lipid nanoparticle-mediated siRNA delivery,intracellular trafficking and endosomal escape [J].Nat Biotechnol, 2013, 31(7): 638-646.
[30]
XUE L L, ZHAO G, GONG N Q, et al.Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery [J].Nat Nanotechnol, 2025, 20(1): 132-143.
[31]
CHEUNG T H, FUCHS A, SHOICHET M S.Acid‐responsive polymer additives increase RNA transfection from lipid nanoparticles [J].Adv Funct Mater, 2025, 35(2):2413220.
[32]
WANG H Y, WANG Y S, YUAN C Z, et al.Polyethylene glycol(PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats [J].NPJ Vaccines, 2023, 8(1): 169.
[33]
KIM J, JOZIC A, LIN Y X, et al.Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation [J].ACS Nano, 2022, 16(9): 14792-14806.
[34]
LIU J, LI R R, FU Q H, et al.Designed microchannel-based lipid nanoparticles encapsulated siRNA targeting gasdermin D for sepsis management via pulmonary delivery [J].Nano Today, 2025, 61: 102653.
[35]
HUANG X G, LIU C, SHARMA S N, et al.Oral delivery of liquid mRNA therapeutics by engineered capsule for treatment of preclinical intestinal disease [J].Sci Transl Med, 2025,17(807): eadu1493.
[36]
MELERO I, CASTANON E, ALVAREZ M, et al.Intratumoural administration and tumour tissue targeting of cancer immunotherapies [J].Nat Rev Clin Oncol, 2021,18(9): 558-576.
[37]
SUN X Q, ZHANG Y, LI J Q, et al.Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy [J].Nat Nanotechnol, 2021, 16(11): 1260-1270.
[38]
KRANZ L M, DIKEN M, HAAS H, et al.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy [J].Nature, 2016, 534(7607): 396-401.
[39]
CHENG Q, WEI T, FARBIAK L, et al.Selective organ targeting(SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing [J].Nat Nanotechnol,2020, 15(4): 313-320.
[40]
FEI Y, YU X L, LIU P Y, et al.Simplified lipid nanoparticles for tissue‐ and cell‐targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model [J].Adv Mater, 2024, 36(48): e2409812.
[41]
LIU S, CHENG Q, WEI T, et al.Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing [J].Nat Mater, 2021, 20(5):701-710.
[42]
LIU J X, GRIMM D.A breath of fresh air: targeted non-viral in vivo gene correction in the mammalian lung [J].Signal Transduct Target Ther, 2024, 9(1): 286.
[43]
PAUNOVSKA K, LOUGHREY D, DAHLMAN J E.Drug delivery systems for RNA therapeutics [J].Nat Rev Genet,2022, 23(5): 265-280.
[44]
SIVARAM A J, WARDIANA A, HOWARD C B, et al.Recent advances in the generation of antibody-nanomaterial conjugates [J].Adv Healthc Mater, 2018, 7(1): 1700607.
[45]
LEE N K, WANG C P J, LIM J, et al.Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities [J].Nano Converg, 2021, 8(1): 24.
[46]
BRÜCKNER M, SIMON J, LANDFESTER K, et al.The conjugation strategy affects antibody orientation and targeting properties of nanocarriers [J].Nanoscale, 2021, 13(21):9816-9824.
[47]
MALECOVA B, BURKE R S, COCHRAN M, et al.Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates(AOCs) [J].Nucleic Acids Res,2023, 51(12): 5901-5910.
[48]
ZHANG Y, GU X Y, HUANG L L, et al.Enhancing precision medicine: bispecific antibody-mediated targeted delivery of lipid nanoparticles for potential cancer therapy [J].Int J Pharm, 2024, 654: 123990.
[49]
LOGAN A, HOWARD C B, HUDA P, et al.Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma [J].J Control Release, 2024, 367: 806-820.
[50]
陶钰萍, 赵珍玉, 李又欣, 等.siRNA新型非病毒载体递送策略新进展[J].中国医药工业杂志, 2023, 54(4): 471-480.
2026年第57卷第3期
122
36
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.03.001
  • 接收时间:2025-05-07
  • 首发时间:2026-11-05
  • 出版时间:2026-03-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-05-07
基金
上海市“科技创新行动计划”生物医药科技支撑专项项目(23S41900200)
上海市“科技创新行动计划”细胞与基因治疗专项项目(23J21900600)
作者信息
    1.中国医药工业研究总院,医药先进制造国家工程研究中心,上海 201203
    2.复旦大学药学院,上海 201203

通讯作者:

何军,研究员,从事新型注射给药系统产业化关键技术的研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.03.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏